Comparison Between Angioplasty Using Compliant and Noncompliant Balloons for Treatment of Cerebral Vasospasm Associated With Subarachnoid Hemorrhage

BACKGROUND Considerable controversy exists regarding the choice of balloon used for performing angioplasty as treatment of cerebral vasospasm associated with subarachnoid hemorrhage. OBJECTIVE To determine the impact of compliant and noncompliant balloons on angiographic and clinical outcomes among patients with subarachnoid hemorrhage–related cerebral vasospasm. METHODS Consecutive patients with cerebral vasospasm who underwent balloon angioplasty were included. Patient characteristics, rate of angiographic recurrence, and occurrence of cerebral infarcts in the affected vessel distribution were compared between arteries treated using different balloons. RESULTS A total of 30 patients underwent a first-time angioplasty using compliant (n = 34) or noncompliant (n = 51) balloons. At admission, patients were classified Hunt and Hess grade I to III (n = 20) and Hunt and Hess grade IV to V (n = 10). Fisher grades in patients were I (n = 1), II (n = 3), III (n = 20), and IV (n = 6). No significant differences in the rate of angiographic recurrence (32% vs 53%; P = .14), need for repeat angioplasty (21% vs 20%; P = .97), and occurrence of cerebral infarcts in the affected arterial distribution (21% vs 10% P = .39) were observed with compliant and noncompliant balloons, respectively. Independent of the balloon type, a significant reduction in the need for repeat angioplasty was observed when the initial angioplasty resulted in a normal or supranormal diameter compared with a subnormal diameter (63.5% vs 36.5%; P = .01). CONCLUSION No clear difference was observed between compliant and noncompliant balloons for therapeutic angioplasty in preventing angiographic recurrence or the need for repeat angioplasty in patients with subarachnoid hemorrhage–related cerebral vasospasm. An immediate normal or supranormal vessel diameter after the first-time angioplasty resulted in a significant reduction in the need for repeat angioplasty.

[1]  A. Qureshi,et al.  Outcomes After Nontraumatic Subarachnoid Hemorrhage at Hospitals Offering Angioplasty for Cerebral Vasospasm: A National Level Analysis in the United States , 2011, Neurocritical care.

[2]  E. Willoughby.  American academy of neurology annual meeting. , 2011, International MS journal.

[3]  A. Qureshi,et al.  A Multicenter Analysis of “Time to Microcatheter” for Endovascular Therapy in Acute Ischemic Stroke , 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[4]  S. Tjoumakaris,et al.  Neuroendovascular management of vasospasm following aneurysmal subarachnoid hemorrhage. , 2009, Neurosurgery clinics of North America.

[5]  Q. Shah,et al.  Super-Selective Intra-arterial Magnesium Sulfate in Combination With Nicardipine for the Treatment of Cerebral Vasospasm in Patients With Subarachnoid Hemorrhage , 2009, Neurocritical care.

[6]  S. Mayer,et al.  Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1): Randomized, Double-Blind, Placebo-Controlled Phase 2 Dose-Finding Trial , 2008, Stroke.

[7]  David M. Rocke,et al.  Effect of Prophylactic Transluminal Balloon Angioplasty on Cerebral Vasospasm and Outcome in Patients With Fisher Grade III Subarachnoid Hemorrhage: Results of a Phase II Multicenter, Randomized, Clinical Trial , 2008, Stroke.

[8]  Martin R. Smith.  Intensive care management of patients with subarachnoid haemorrhage , 2007, Current opinion in anaesthesiology.

[9]  H. Woo,et al.  US Multicenter Experience With the Wingspan Stent System for the Treatment of Intracranial Atheromatous Disease: Periprocedural Results , 2007, Stroke.

[10]  C. Derdeyn,et al.  Safety and technical efficacy of over-the-wire balloons for the treatment of subarachnoid hemorrhage-induced cerebral vasospasm. , 2006, Neurosurgical focus.

[11]  David F Kallmes,et al.  Subarachnoid hemorrhage: neurointensive care and aneurysm repair. , 2005, Mayo Clinic proceedings.

[12]  Robyn L McClelland,et al.  Predictors of outcome after endovascular treatment of cerebral vasospasm. , 2004, AJNR. American journal of neuroradiology.

[13]  S. Finfer,et al.  Aggressive management of aneurysmal subarachnoid haemorrhage based on a papaverine angioplasty protocol , 2000, Journal of Clinical Neuroscience.

[14]  J. Ulatowski,et al.  Early predictors of outcome in patients receiving hypervolemic and hypertensive therapy for symptomatic vasospasm after subarachnoid hemorrhage , 2000, Critical care medicine.

[15]  D. Warner,et al.  Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options , 1999 .

[16]  R. A. Solomon.  Role of Transcranial Doppler Monitoring in the Diagnosis of Cerebral Vasospasm after Subarachnoid Hemorrhage , 1999 .

[17]  M. Suarez‐Almazor,et al.  Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage , 1999, Neurosurgery.

[18]  R. Armonda,et al.  Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. , 1999, Neurosurgery.

[19]  H. Winn,et al.  Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. , 1998, Neurosurgery.

[20]  J. P. Elliott,et al.  Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. , 1997, Journal of neurosurgery.

[21]  J. Torner,et al.  Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. , 1995, Critical care medicine.

[22]  Aman B Patel,et al.  Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association , 1994, Stroke.

[23]  H. Adams,et al.  Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. , 1994, Stroke.

[24]  J. Broderick,et al.  Initial and Recurrent Bleeding Are the Major Causes of Death Following Subarachnoid Hemorrhage , 1994, Stroke.

[25]  R. R. Smith,et al.  Angioplasty of vasospasm: is it reasonable? , 1994, Neurological research.

[26]  N. Dorsch,et al.  A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage Part I: Incidence and effects , 1994, Journal of Clinical Neuroscience.

[27]  D. Newell,et al.  Transluminal angioplasty for treatment of vasospasm. , 1990, Neurosurgery clinics of North America.

[28]  R. Higashida,et al.  Transluminal angioplasty for treatment of intracranial arterial vasospasm. , 1989, Journal of neurosurgery.

[29]  W. Hunt,et al.  Intracranial aneurysm. A nine-year study. , 1966, The Ohio State medical journal.

[30]  T. Itakura,et al.  The effect of endovascular therapy for cerebral arterial spasm, its limitation and pitfalls , 2005, Acta Neurochirurgica.

[31]  M. Lipton.  Intracranial aneurysms. , 1997, The New England journal of medicine.

[32]  Fisher Cm,et al.  Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. , 1980, Neurosurgery.

[33]  W. Hunt,et al.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms. , 1968, Journal of neurosurgery.